Antony, France

Bruno H Muller

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Biomerieux, Inc., Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2017.


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bruno H Muller: Innovator in RNA Polymerase Technology

Introduction

Bruno H Muller is a notable inventor based in Antony, France. He has made significant contributions to the field of molecular biology, particularly through his work on RNA polymerases. His innovative approach has led to advancements that are crucial for various applications in biotechnology.

Latest Patents

One of Bruno H Muller's key patents is related to mutated T7 RNA polymerases. The invention pertains to a mutated T7 RNA polymerase that is altered at position 744, where the glutamine (Q) is replaced by an amino acid selected from arginine (Q744R), leucine (Q744L), or proline (Q744P). This patent represents a significant advancement in the functionality of RNA polymerases, enhancing their utility in research and industrial applications. He holds 1 patent in this area.

Career Highlights

Throughout his career, Bruno H Muller has worked with prominent organizations, including bioMérieux, Inc. and the Commissariat à l'énergie atomique et aux énergies alternatives. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to the advancement of biotechnology.

Collaborations

Bruno has collaborated with several professionals in his field, including Jean-Claude Boulain and Janie Dassa. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Bruno H Muller is a distinguished inventor whose work on mutated T7 RNA polymerases has made a significant impact in the field of molecular biology. His contributions continue to influence advancements in biotechnology and research applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…